84 results
Page 4 of 5
6-K
EX-99.1
nm6wnmsbp4h15
3 Jan 20
Gamida Cell Announces Completion of Patient Enrollment in Ongoing Phase 3 Clinical Study of Omidubicel
6:03am
F-3
422ra15n
14 Nov 19
Shelf registration (foreign)
5:11pm
F-3
EX-1.2
h3ibxw zfil7653fn4
14 Nov 19
Shelf registration (foreign)
5:11pm
6-K
EX-99.2
p446ucgoxx851 lb3c
7 Aug 19
Current report (foreign)
1:58pm
6-K
EX-99.1
hk6t w5ty2bkcl743j1c
8 Jul 19
Gamida Cell Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
12:57pm
424B4
3yqytz2gu
28 Jun 19
Prospectus supplement with pricing info
3:51pm
F-1/A
pl1 92qy0
26 Jun 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-1.1
rl9an
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
EX-10.14
51okdiya
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
yed8ks
24 Jun 19
Registration statement (foreign)
4:04pm
6-K
EX-99.1
xk8aq6sm1rra2lmx2sts
31 May 19
Gamida Cell Announces Data for Omidubicel Presented at the International Society for Cellular and Gene Therapy 2019 Annual Meeting
8:45am
20-F
w1skec f9c5cy7f
25 Feb 19
Annual report (foreign)
5:08pm
6-K
EX-99.1
hve94vf3t256l4h2m
25 Feb 19
Gamida Cell Announces Immune Reconstitution Data from Completed Phase 1/2 Clinical Study of NiCord® Presented at 2019 TCT Annual Meeting
6:08am
DRS
o6jndt2gvw38aft kkc
15 Feb 19
Draft registration statement
12:00am
424B4
nu69phw
30 Oct 18
Prospectus supplement with pricing info
8:35am
FWP
h25vx i8nzyyely15
26 Oct 18
Free writing prospectus
9:39am
F-1/A
80qmdjwx9ah0 j4
17 Oct 18
Registration statement (foreign) (amended)
6:06am
F-1/A
EX-1.1
9bd11i
17 Oct 18
Registration statement (foreign) (amended)
6:06am
F-1
8vv4quhr 13krf3y32p3
28 Sep 18
Registration statement (foreign)
4:29pm
F-1
EX-10.7
tp7jeiq7y 2h8h
28 Sep 18
Registration statement (foreign)
4:29pm